Cargando…

Understanding Kidney Diseases

This book provides the essential understanding needed for the assessment of patients with kidney disease. The chapters follow the sequence taken during a clinic consultation and when clerking a patient. At each stage, the principles and concepts underlying aspects of renal medicine that may seem dif...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Rayner, Hugh C. (Autor), Thomas, Mark (Autor), Milford, David (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2016.
Edición:1st ed. 2016.
Temas:
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • Introduction
  • The purpose of the book - understanding the natural history of kidney disease
  • how displaying a GFR history is a fundamental part of the clinical assessment of kidney diseases
  • how the eGFR graph is used to inform patients and plan treatment.-principles but not details of treatment
  • The basics of creatinine measurement and eGFR equations in adults
  • Simple guide to the classification of AKI, AKD and CKD
  • Stages of CKD - including proteinuria
  • The meaning of 'stability' in an eGFR graph - variation over time
  • Cases
  • Section 1: Acute kidney injury - changes over 50% drop, assuming no asymmetry)
  • Recurrent AKI leading to CKD
  • Section 2: AKD - changes >48 hours 3months
  • Patterns of progression - Linear and Non-linear
  • Monitoring response to treatment - e.g. immunosuppression for GN, BP control in malignant hypertension
  • Section 4: CKD - changes over years
  • non-progressive (stable) CKD  - e.g. obstructive uropathy
  • progressive CKD - e.g. transplant nephropathy, lithium nephrotoxicity, role of proteinuria as risk marker
  • Use of graphs to plan future renal replacement therapy - e.g. linear progression in ADPKD
  • Section 5: Acute-on-chronic kidney disease
  • Chronic slowly progressive diabetic nephropathy with superimposed acute pathology, e.g. response to ACEI/ARB, contrast nephropathy, glomerulonephritis, interstitial nephritis
  • Transplant rejection
  • Pregnancy in women with CKD
  • Section 6: Nephrotic syndrome
  • GFR, serum albumin and urinary PCR graphs - use to monitor treatment and relapses, and to plan treatment
  • Section 7: Other graphs
  • 24 hour BP measurement - importance of nocturnal dip and timing of antihypertensives in CKD care
  • Diabetes mellitus - HbA1c - colour coding as patient education tool; role of glucose control in preventing diabetic nephropathy (but no impact once CKD established)
  • Serum free light chains and myeloma kidney/light chain nephropathy/immune GN
  • Conclusions
  • eGFR graphs - an essential tool in patient assessment which tells the story of kidney disease
  • The role of graphs (eGFR, 24 hour BP, and HbA1c) in patient education and support of self-management
  • Role of eGFR graphs in systematic CKD surveillance by renal units and pathology labs - evidence of benefit.